Wang, Xinlu, Tu, Fan, Zhu, Yiping et al. · PloS one · 2012 · DOI
This study investigates how a human immune protein called ZAP (zinc-finger antiviral protein) blocks a virus called XMRV from multiplying in cells. Researchers found that when cells produce more ZAP, XMRV cannot spread effectively, and when ZAP levels are reduced, cells become more vulnerable to the virus. The study shows that ZAP works by targeting and destroying the virus's genetic instructions before they can be used to make new virus particles.
This research is relevant to ME/CFS because XMRV was previously controversial in ME/CFS research; understanding its molecular biology and host immune responses may inform ongoing investigations into viral contributions to ME/CFS pathogenesis. Characterizing how human antiviral proteins like ZAP control retroviral replication provides insights into endogenous immune mechanisms that could be dysregulated in ME/CFS patients.
This study does not establish that XMRV causes ME/CFS or that ZAP dysfunction contributes to ME/CFS pathology. The authors note that XMRV itself was later determined to be a laboratory artifact, so findings about XMRV inhibition do not directly indicate active viral involvement in disease. The study is mechanistic in cell culture and does not address whether ZAP dysfunction occurs in ME/CFS patients or affects disease outcomes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →